|4Aug 29, 6:27 PM ET

Daly Timothy 4

4 · Ovid Therapeutics Inc. · Filed Aug 29, 2018

Insider Transaction Report

Form 4
Period: 2018-08-27
Daly Timothy
VP, Finance & Corp. Controller
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-08-27+11,25011,250 total
    Exercise: $6.40Exp: 2028-08-27Common Stock (11,250 underlying)
Footnotes (1)
  • [F1]The option, representing a right to purchase a total of 11,250 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date.

Documents

2 files